COLORECTAL CANCER CANADA
Colorectal Cancer Canada is the nation’s non-profit colorectal cancer patient organization. We are dedicated to colorectal cancer awareness and education, supporting patients and caregivers, and advocating on their behalf. Our goal is to reduce the incidence and mortality of colorectal cancer in Canada and to improve the quality of life for patients, their families and caregivers.

69
Canadians diagnosed every day
4th
Most commonly diagnosed cancer in Canada in 2024
90%
Curable when
diagnosed at early stages
COLORECTAL CANCER
SYMPTOMS
Become familiar with common colorectal cancer symptoms, such as unexplained changes to bowel habits, rectal bleeding, and abdominal pain and discomfort. If you notice any, be sure to inform your doctor as soon as possible. When caught early, colorectal cancer is highly treatable.
COLORECTAL CANCER
RISK FACTORS
Find out more about the factors that increase the chance of developing colorectal cancer. Knowing your risk factors and discussing them with your doctor can help you make more informed health care choices, such as participating in screening at an earlier age if necessary.
COLORECTAL CANCER
RISK FACTORS
Find out more about the factors that increase the chance of developing colorectal cancer. Knowing your risk factors and discussing them with your doctor can help you make more informed health care choices, such as participating in screening at an earlier age if necessary.
SCREENING AND
PREVENTION
Keeping up to date with colorectal cancer screening is an important part of prevention. A screening test checks for colorectal cancer when there are no signs and symptoms of the disease. Participating in screening helps to remove precancerous polyps and detect colorectal cancer at an earlier stage when it is more treatable.
SCREENING AND
PREVENTION
Keeping up to date with colorectal cancer screening is an important part of prevention. A screening test checks for colorectal cancer when there are no signs and symptoms of the disease. Participating in screening helps to remove precancerous polyps and detect colorectal cancer at an earlier stage when it is more treatable.
NEWLY DIAGNOSED WITH
COLORECTAL CANCER?
We’ve been there, and we are here to help you every step of the way. It is important to begin by gathering the resources you need to be your best advocate. There have been many new advances in colorectal cancer patient care – we want you to be aware of the latest information.
NEWLY DIAGNOSED WITH
COLORECTAL CANCER?
We’ve been there, and we are here to help you every step of the way. It is important to begin by gathering the resources you need to be your best advocate. There have been many new advances in colorectal cancer patient care – we want you to be aware of the latest information.
UPCOMING EVENTS
THURSDAY, JULY 17th, 2025 We are very happy to announce that the 2025 Kick Ass Golf tournament will take place on July 17th at the beautiful Angus Glen Golf Course. We had a very successful event last year and we hope to have even more golfers join us this year! PLEASE SAVE THE DATE: JULY 17th, 2025! Stay tuned for ...
LATEST NEWS
A randomized phase 3 trial (CHALLENGE, CO.21) conducted by the Canadian Cancer Trials Group found that a 3-year structured exercise program following surgery and chemotherapy significantly improved outcomes for patients with stage III and high-risk stage II colorectal cancer. Compared to patients who only received health education materials, those in ...
New results from the Phase 3 BREAKWATER clinical trial show that a combination treatment including BRAFTOVI® (encorafenib), cetuximab, and chemotherapy significantly improves survival for patients with metastatic colorectal cancer that has a specific genetic change called the BRAF V600E mutation. In the trial, patients receiving this new treatment lived twice ...
A large phase 3 trial (ASCOLT) found that daily aspirin use for 3 years after standard adjuvant therapy (treatment given to patients following surgery) did not improve disease-free survival in an unselected population of colorectal cancer patients. Conducted across 11 countries with 1,550 participants, the study showed no statistically significant ...